C-Path Roundtable: C-Path, Help4HD Unite to Discuss Advancements in Huntington's Disease Treatments

Thomas Hart, Director of Outreach for Critical Path Institute’s Rare and Orphan Diseases program and program Executive Director Terina Martinez were joined by Jackson and Lauren Holder, Help4HD Radio’s producer and host, on Huntington's Disease Awareness Day. In the time that four spent together, the vigor, drive, compassion, and desire were on full display from four people who spend their lives advocating for people living with HD, researching better treatments, living with the disease, and/or seeing loved ones live with it.

SUBSCRIBE to C-Path's YouTube Channel Now ►►    / criticalpathinstitute  

FOLLOW C-Path:

►LinkedIn:   / c-path  

►Facebook:   / cpathinstitute  

►Twitter: https://twitter.com/CPathInstitute?re

About Critical Path Institute

C-Path is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.

#CPath #drugdiscovery #researchgrants #globalhealth #drugdevelopment #datasharing #researchfunding #raredisease #academicresearch #regulatoryscience #globalhealth #consortia #collaboration #FDA #EMA #T1D #Parkinsons #Alzheimers #PKD #Duchenne #ALS #biomarkers